About Foresee Biosystems
Foresee Biosystems is a Healthcare company based in Genoa (Italy) founded in 2021 by Michele Dipalo. Developer of in vitro assays for detection of potential toxicity in drug discovery. Its chief executive, as recorded, is Giovanni Melle. Foresee Biosystems offers products and services including IntraCell. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is Foresee biosystems srl.
Company details
Foresee Biosystems was founded in 2021 in Genoa, Italy, within the biotechnology sector focused on drug discovery. In vitro Micro Electrode Array (MEA) assays are created using laser technology to assess potential toxicological effects on cellular models. Acute and chronic cardiotoxicity in cardiac cells can be measured through these assays, supporting early-stage toxicity prediction for pharmaceutical development.
- Headquarters Genoa, Italy
- Founders Michele Dipalo
- SectorsHealthcare
- Email••••••••
- Website foreseebiosystems.com
- Social LinkedIn X
- Legal Name Foresee Biosystems Srl
- Latest Funding Round$868.91K (USD), Grant
Apr 2022
- Investors
Products & Services of Foresee Biosystems
Foresee Biosystems offers a comprehensive portfolio of products and services, including IntraCell.
Enables recordings of action potentials from cardiomyocytes for toxicity prediction.
Funding Insights of Foresee Biosystems
- Total Rounds 1
- Last Round Grant — $868,907
- First Round $868,907
(Apr 2022)
- Investors Count 1
All 1 funding rounds of Foresee Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | $868,907 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Foresee Biosystems
Foresee Biosystems has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Foresee Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Foresee Biosystems
2 people are tracked at Foresee Biosystems (2 in leadership).
| Name | Role | Group |
|---|---|---|
Michele Dipalo | Founder | Leadership |
Giovanni Melle | CEO | Leadership |
Complete people profiles for Foresee Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Foresee Biosystems
2 dated milestones of Foresee Biosystems across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Foresee Biosystems is founded.
- Funding First funding round of $869K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Foresee Biosystems
Foresee Biosystems was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Foresee Biosystems is headquartered in Genoa, Italy. It is registered at Genoa, Liguria, Italy.
Giovanni Melle is the CEO of Foresee Biosystems, as recorded in our data.
Foresee Biosystems was founded in 2021 in Genoa, Italy, within the biotechnology sector focused on drug discovery. In vitro Micro Electrode Array (MEA) assays are created using laser technology to assess potential toxicological effects on cellular models. Acute and chronic cardiotoxicity in cardiac cells can be measured through these assays, supporting early-stage toxicity prediction for pharmaceutical development.
Foresee Biosystems offers IntraCell.
Foresee Biosystems has 1 investor. Key investors include European Union.
Foresee Biosystems operates through Foresee Biosystems Srl.